First China Pharmaceutical Group reported that due diligence has begun on its proposed acquisition of Shenzhen Ming He Tang Pharmaceutical Co., a drug distributor whose South China business will open new territory for First China. First China announced a MOU to buy Ming He Tang in March. First China also said its acquisition of Shandong Run Kang Pharma has now been put on hold.
